Wednesday, March 18, 2020 - The New York Times weighed in last week on the proposed switch that Gilead Sciences was making in urging their patients to switch from Truvada with its superior effectiveness and dangerous side effects to Descovy, a drug with arguably neither but touted to have greater effectiveness in fighting the AIDs virus and less adverse side effects also. Gilead has been accused in lawsuits of deliberately keeping Descovy off of the market until now to maximize profits on Truvada, a $2000 per bottle, per month, per patient cash cow. The New York Times cites a study of the switch and claims that transitioning to the new drug is not worth the added cost. Generic competition is set to cut an HIV patient's cost by around 50% to about $8000, however, family physicians are more concerned with the drug's side effects than cost.
Generic drugs that mimic Truvada also may cause bone density issues and kidney problems. Descovy has shown to have fewer reported side effects such as these. "Doctors may instead choose to prescribe a newer brand-name PrEP pill, Descovy, that costs about $16,600 because it may have a lower risk of certain side effects sometimes seen with Truvada including kidney damage and fractures. Over five years, researchers calculated that switching 123,610 patients from Truvada to Descovy might prevent 2,101 fractures and 25 cases of advanced kidney failure," the Times pointed out. It should also be remarked that family physicians, in general, are hesitant to perform a mandatory HIV test on all of their patients and are averse to prescribing any HIV-transmission drug because they say to do so would be granting homosexuals a license to have unprotected sex and transmit many other deadly sexual diseases. If you have suffered brittle and broken bones or kidney failure from taking Truvada, Truvada lawyers offer a free consultation to advise individuals if they qualify to file a claim.
The New York Times admission of Truvada and generic copycat drug's adverse side effects is contrary to what AIDS health activists would like the community to believe. LGBTQ groups have protested and insisted that lawyers advertising for Truvada side effects clients remove their social media ads because they allege the ads are scaring potential patients away from using the drug for daily AIDS management and HIV transmission prevention. Reuters reported that advocates felt that the ads exaggerated the rates at which Truvada patients would suffer from bone breakages and some require kidney dialysis and possibly a kidney transplant. Reuters wrote: "Nunn, an associate professor of public health and medicine at Brown University in Providence, Rhode Island, says the advertisements "grossly overstate" rates of side effects like renal failure and bone loss." Facebook removed some ads but the majority continue to be run targeting people with previously HIV-weakened immune systems that are potentially susceptible to Truvada's toxicity.
Advocates for generic drug competition in this field of medicine cite the savings that the Federal government could make by buying and giving away cheaper generic HIV prevention and management drugs and that the savings could be reallocated to AIDS educational programs targeting higher at-risk groups like poorer black and Latino teenage homosexuals.
OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The firm has represented thousands of persons in these and other products liability litigation, including DePuy hip replacement systems, which settled for $2.5 billion and Pradaxa internal bleeding, which settled for $650 million. The Onder Law Firm won over $300 million in four talcum powder ovarian cancer lawsuits in St. Louis to date and other law firms throughout the nation often seek its experience and expertise on complex litigation.